TITLE

Product Patents on drugs and Medicines - A critique

AUTHOR(S)
Patil, Dinesh kumar D.
PUB. DATE
August 2012
SOURCE
Indian Streams Research Journal;Aug2012, Vol. 2 Issue 7, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
India has shifted to a new product patent regime from process patents which was considered as a transition period from 1995-200, All the developing countries and least developed countries were under an obligation to amend the Patent Laws in their respective countries to meet the norms of minimum standard as envisaged in the TRIPS Agreement although there were oppositions from all the corners of the world but the Doha declaration was brought to cover up the loop holes to protect the public health by providing flexibilities which were not clearly made out the paper discusses how it affected the general public in having access to life saving drugs and what steps can be taken in the light of stricter norms of IPR regimes.
ACCESSION #
82588919

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics